We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Immunization With Live Attenuated Rubella Virus Vaccine (HPV-77) Clinical and Serological Results in Children and Adolescents in Israel

Natan Goldblum, PhD; Tiberio A. Swartz, MD; Wanda Klingberg, PhD; Robert A. Goldwasser, PhD; Marcus A. Klingberg, MD
Am J Dis Child. 1969;118(2):190-196. doi:10.1001/archpedi.1969.02100040192006.
Text Size: A A A
Published online


THE experience with live attenuated rubella virus vaccines which has accumulated in the last few years shows a clear need for a rubella vaccine that is not only safe and effective, but also has few or no side affects when recommended as a routine procedure. Age seems to affect the intensity of the clinical response to vaccine administration, and, since joint manifestations have been reported in adult women immunized with rubella vaccine,1-3 it was considered desirable to study the age effect further by investigating the clinical and serological reactions in a broad age spectrum of susceptible women.

For this purpose a field trial was initiated in Israel during the autumn and winter months of 1968 and 1969 which included a representative number of female subjects of various ages. The preliminary observations of the trial are presented in this report.

Materials and Methods  Study Group.—This group included 239 girls,


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.